Prognostic Factors After Index Hospitalization for Heart Failure With Preserved Ejection Fraction

American Journal of Cardiology

Volumn 119, Issue 12, 2017, Pages 2017-2020

  Huang, Weiting ^a   Chai, Siang Chew ^a   Lee, Shao Guang Sheldon ^a   MacDonald, Michael R ^a   Leong, Kui Toh Gerard ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ASIAN; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SHORT TERM SURVIVAL; CAUSE OF DEATH; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; INCIDENCE; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SINGAPORE; SURVIVAL RATE; TRENDS;

AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SINGAPORE; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 85018956776     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2017.03.032     Document Type: Article

References (19)

1. 1 Persson, H., Lonn, E., Edner, M., Baruch, L., Lang, C.C., Morton, J.J., Ostergren, J., McKelvie, R.S., Investigators of the CHARM Echocardiographic Substudy-CHARMES. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 49 (2007), 687–694.
2. 2 Abhayaratna, W.P., Marwick, T.H., Smith, W.T., Becker, N.G., Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart Br Card Soc 92 (2006), 1259–1264.
3. 3 Shah, A.M., Claggett, B., Sweitzer, N.K., Shah, S.J., Anand, I.S., Liu, L., Pitt, B., Pfeffer, M.A., Solomon, S.D., Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 132 (2015), 402–414.
4. 4 McKee, P.A., Castelli, W.P., McNamara, P.M., Kannel, W.B., The natural history of congestive heart failure: the Framingham study. N Engl J Med 285 (1971), 1441–1446.
5. 5 Januzzi, J.L., van Kimmenade, R., Lainchbury, J., Bayes-Genis, A., Ordonez-Llanos, J., Santalo-Bel, M., Pinto, Y.M., Richards, M., NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006), 330–337.
6. 6 Nagueh, S.F., Appleton, C.P., Gillebert, T.C., Marino, P.N., Oh, J.K., Smiseth, O.A., Waggoner, A.D., Flachskampf, F.A., Pellikka, P.A., Evangelista, A., Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 22 (2009), 107–133.
7. 7 Kraigher-Krainer, E., Shah, A.M., Gupta, D.K., Santos, A., Claggett, B., Pieske, B., Zile, M.R., Voors, A.A., Lefkowitz, M.P., Packer, M., McMurray, J.J.V., Solomon, S.D., PARAMOUNT Investigators. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 63 (2014), 447–456.
8. 8 Shah, A.M., Claggett, B., Sweitzer, N.K., Shah, S.J., Anand, I.S., O'Meara, E., Desai, A.S., Heitner, J.F., Li, G., Fang, J., Rouleau, J., Zile, M.R., Markov, V., Ryabov, V., Reis, G., Assmann, S.F., McKinlay, S.M., Pitt, B., Pfeffer, M.A., Solomon, S.D., Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail 7 (2014), 740–751.
9. 9 Katz, D.H., Beussink, L., Sauer, A.J., Freed, B.H., Burke, M.A., Shah, S.J., Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction. Am J Cardiol 112 (2013), 1158–1164.
10. 10 Tribouilloy, C., Rusinaru, D., Mahjoub, H., Soulière, V., Lévy, F., Peltier, M., Slama, M., Massy, Z., Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 29 (2008), 339–347.
11. 11 Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
12. 12 de Groot, V., Beckerman, H., Lankhorst, G.J., Bouter, L.M., How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 56 (2003), 221–229.
13. 13 Bursi, F., Weston, S.A., Redfield, M.M., Jacobsen, S.J., Pakhomov, S., Nkomo, V.T., Meverden, R.A., Roger, V.L., Systolic and diastolic heart failure in the community. JAMA 296 (2006), 2209–2216.
14. 14 Yancy, C.W., Lopatin, M., Stevenson, L.W., De Marco, T., Fonarow, G.C., Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 (2006), 76–84.
15. 15 Fonarow, G.C., Stough, W.G., Abraham, W.T., Albert, N.M., Gheorghiade, M., Greenberg, B.H., O'Connor, C.M., Sun, J.L., Yancy, C.W., Young, J.B., OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50 (2007), 768–777.
16. 16 Steinberg, B.A., Zhao, X., Heidenreich, P.A., Peterson, E.D., Bhatt, D.L., Cannon, C.P., Hernandez, A.F., Fonarow, G.C., Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126 (2012), 65–75.
17. 17 Gorcsan, J., Tanaka, H., Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 58 (2011), 1401–1413.
18. 18 Patrianakos, A.P., Zacharaki, A.A., Kalogerakis, A., Solidakis, G., Parthenakis, F.I., Vardas, P.E., Two-dimensional global and segmental longitudinal strain: are the results from software in different high-end ultrasound systems comparable?. Echo Res Pract 2 (2015), 29–39.
19. 19 Haass, M., Kitzman, D.W., Anand, I.S., Miller, A., Zile, M.R., Massie, B.M., Carson, P.E., Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 4 (2011), 324–331.